193 related articles for article (PubMed ID: 34819659)
1. The CRISPR children.
Marx V
Nat Biotechnol; 2021 Dec; 39(12):1486-1490. PubMed ID: 34819659
[No Abstract] [Full Text] [Related]
2. The Biology and Application Areas of CRISPR Technologies.
Adli M
J Mol Biol; 2019 Jan; 431(1):1-2. PubMed ID: 30447221
[No Abstract] [Full Text] [Related]
3. Meeting Report: German Genetics Society-Genome Editing with CRISPR.
Maier LK; Marchfelder A; Randau L
Bioessays; 2020 Feb; 42(2):e1900223. PubMed ID: 31853989
[No Abstract] [Full Text] [Related]
4. CRISPR-Cas9 System: Opportunities and Concerns.
Vasiliou SK; Diamandis EP; Church GM; Greely HT; Baylis F; Thompson C; Schmitt-Ulms G
Clin Chem; 2016 Oct; 62(10):1304-11. PubMed ID: 27551006
[No Abstract] [Full Text] [Related]
5. Whole-body CRISPR editing.
Perdigoto CN
Nat Struct Mol Biol; 2022 Aug; 29(8):729. PubMed ID: 35948771
[No Abstract] [Full Text] [Related]
6. Henceforth CRISPR.
Nat Biomed Eng; 2020 Nov; 4(11):1023. PubMed ID: 33060800
[TBL] [Abstract][Full Text] [Related]
7. Twelve genes at one blow: multiplex genome editing with CRISPR/Cas.
Verhage L
Plant J; 2021 Apr; 106(1):6-7. PubMed ID: 33861513
[No Abstract] [Full Text] [Related]
8. Celebrating a Decade of CRISPR-Fueled Genome Editing.
Barrangou R
CRISPR J; 2022 Jun; 5(3):354-355. PubMed ID: 35686974
[No Abstract] [Full Text] [Related]
9. Refining CRISPR-based genome and epigenome editing off-targets.
Luo Y
Cell Biol Toxicol; 2019 Aug; 35(4):281-283. PubMed ID: 31227932
[No Abstract] [Full Text] [Related]
10. Foresight is 2020: Ten Bold Predictions for the New CRISPR Year.
Barrangou R
CRISPR J; 2019 Dec; 2(6):341-342. PubMed ID: 31860348
[No Abstract] [Full Text] [Related]
11. CRISPR Keeps Things Fresh: Next-Generation Tools for Gene Editing.
Flotte TR
Hum Gene Ther; 2021 Mar; 32(5-6):235-236. PubMed ID: 33750218
[No Abstract] [Full Text] [Related]
12. CRISPR Rewrites the Future of Medicine.
Barrangou R
CRISPR J; 2022 Feb; 5(1):1. PubMed ID: 35191754
[No Abstract] [Full Text] [Related]
13. Assessing Off-Target Editing of CRISPR-Cas9 Systems.
Pruett-Miller SM
CRISPR J; 2020 Dec; 3(6):430-432. PubMed ID: 33346715
[No Abstract] [Full Text] [Related]
14. Thinking About CRISPR: The Ethics of Human Genome Editing.
Barrangou R
CRISPR J; 2019 Oct; 2(5):247-248. PubMed ID: 31599676
[No Abstract] [Full Text] [Related]
15. Use of CRISPR/Cas Genome Editing Technology for Targeted Mutagenesis in Rice.
Xu R; Wei P; Yang J
Methods Mol Biol; 2017; 1498():33-40. PubMed ID: 27709567
[TBL] [Abstract][Full Text] [Related]
16. CRISPR Milestones and Anticipating What Is Next for the Journal.
Barrangou R
CRISPR J; 2021 Dec; 4(6):771-772. PubMed ID: 34935490
[No Abstract] [Full Text] [Related]
17. CRISPR technology.
Nat Biotechnol; 2022 Jun; 40(6):832. PubMed ID: 35705705
[No Abstract] [Full Text] [Related]
18. CRISPR-Cas9: A revolution in genome editing in rheumatic diseases.
Duroux-Richard I; Giovannangeli C; Apparailly F
Joint Bone Spine; 2017 Jan; 84(1):1-4. PubMed ID: 27825565
[No Abstract] [Full Text] [Related]
19. Editorial: CRISPR and alternative approaches.
Kapusi E; Cong L; Stoger E
Biotechnol J; 2022 Jul; 17(7):e2200290. PubMed ID: 35726663
[No Abstract] [Full Text] [Related]
20. Broad defeats Berkeley CRISPR patent.
Shaffer C
Nat Biotechnol; 2022 Apr; 40(4):445. PubMed ID: 35288688
[No Abstract] [Full Text] [Related]
[Next] [New Search]
